Dan Williams interviewed on NBC about the impacts of proposed cuts on rare disease researchDr Dan WilliamsJul 211 min readFind out how Trump's proposed NIH cuts have caused concern over rare disease research > here.
Drug Target Review features an insightful article by Dan Williams that explores the extraordinary achievements of AI in drug design
Technology Networks features a major interview with Dr Uwe Meya, SynaptixBio’s CMO, in which the issues around organising, funding, and conducting clinical trials for rare diseases are discussed.
Dan Williams contributes to a major article for Inside Precision Medicine, in which several US families with a child living with H-ABC discuss their journey to a diagnosis
